Nephrocare Health Services IPO Analyzed

Nephrocare Health Services, a company providing dialysis services, is holding an initial public offering (IPO) starting December 10, 2025. The company wants to raise ₹871.05 crore, which includes selling both new shares and allowing existing shareholders to sell some of their shares. This is a big step for the company and could be a good opportunity for investors.

Key Points

• Company raises ₹871.05 crore via share sale.
• ₹260 crore raised from investors before the IPO.
• Price band: ₹438 – ₹460 per share (lot size 32 shares).
• IPO open until Friday, December 12, 2025.
• Listing expected on Wednesday, December 17, 2025.
• Funds used for new clinics and paying off debts.

IPO Structure

The IPO includes two parts. First, Nephrocare will sell up to 7.7 million new shares, aiming to raise ₹353.40 crore. Second, existing shareholders can sell up to 11.3 million shares, which could bring in approximately ₹517.64 crore. It’s important to know that the company itself won’t get any money from the sale of shares – that money will go to the people who are selling their shares.

Targeting Investors

Nephrocare is trying to attract different types of investors. At least 50% of the shares will go to big investors (Qualified Institutional Buyers), 35% will be for regular investors (Retail Investors), and 15% for smaller investors (Non-Institutional Investors). This shows they want to get a broad range of people involved in the company.

Investment Details

Investors can bid for shares at a price between ₹438 and ₹460. To buy just 32 shares, an investor needs to spend at least ₹14,720. Someone who wants to buy a maximum amount of shares (416 shares) will need to spend ₹1,91,360.

Grey Market Premium and Dates

Based on unconfirmed market activity, the shares were trading at the top end of the IPO price range. This means the “grey market premium” is currently zero. The IPO will close for subscription on December 12, 2025, and the results will be announced on December 15, 2025. Shares will be listed on December 17, 2025.

Companies Involved

KFin Technologies is managing the IPO registration, while ICICI Securities and other companies are helping organize the sale. These companies are experts in helping companies like Nephrocare go public.

“Ultimately, a successful IPO signifies a company’s growth and opportunity to serve more patients.”